Hair Relaxer Lawsuit Eligibility & Case-Value Tracker
Active MDL — 9,800+ federal cases (2025), no settlement yet. Filed against L’Oréal, SoftSheen-Carson, Strength of Nature, and others over chemical-relaxer links to uterine, endometrial, ovarian cancer and uterine fibroids.
Last reviewed: April 2026
⚠️ NO SETTLEMENT YET. This is an active multi-district litigation. Any per-person dollar figures on this page are LAWYER ESTIMATES from comparable mass torts — not verdicts, not settlement payouts.
Your Case Details
Answer a few questions to see your estimated range.
Higher-tier injuries qualify for higher settlement tiers.
Estimated Settlement Tier
$105,000 — $195,000
Mass tort settlements use injury-severity tiers. Most MDLs have published payment matrices — your tier depends on diagnosis + exposure proof.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
The Hair Relaxer MDL — What’s Happening
Following a major 2022 NIH-funded Sister Study publication associating frequent chemical hair-relaxer use with elevated rates of uterine cancer, thousands of plaintiffs began filing suit against the manufacturers. Cases were consolidated into a federal multidistrict litigation (MDL) in the Northern District of Illinois before Judge Mary M. Rowland.
Named defendants include L’Oréal USA, SoftSheen-Carson (L’Oréal subsidiary), Strength of Nature, and additional manufacturers and distributors. The complaints allege the products contained phthalates and other endocrine-disrupting chemicals known or knowable to increase risk of uterine cancer, endometrial cancer, ovarian cancer, and uterine fibroids — without adequate warning to consumers.
As of 2025 there are approximately 9,800+ active cases in the MDL (up from ~7,800 in 2024). The MDL is in active discovery and bellwether-selection phase. No settlement has been reached. No payouts have been distributed. No claim form exists. Anyone telling you a Hair Relaxer payout is guaranteed is misinforming you. Court: U.S. District Court, Northern District of Illinois. Judge: Mary M. Rowland.
Example Eligibility Profiles
These illustrative profiles show how MDL plaintiffs’ attorneys typically tier prospective cases. <strong>Dollar amounts are lawyer estimates only.</strong>
Profile 1 — Multi-Year Use, Uterine Fibroids
Used Dark & Lovely and Just for Me relaxers approximately every 6–8 weeks from age 15 through age 38. Diagnosed with uterine fibroids requiring myomectomy at 40.
Lawyer-estimated tier: Tier 1 (~$75K–$200K). Estimate only — actual outcome depends on documentation, expert testimony on causation, and bellwether verdicts.
Profile 2 — Long-Term Use, Endometrial Cancer
Used various salon-applied relaxers from teen years through her 40s. Diagnosed with endometrial cancer at 47; treated with hysterectomy and chemotherapy.
Lawyer-estimated tier: Tier 2 (~$200K–$600K). Estimate only — actual case value depends on bellwether outcomes and individual causation strength.
Profile 3 — Uterine Cancer, Severe Outcome
Decades of monthly chemical relaxer use, well documented through salon receipts and photos. Diagnosed with aggressive uterine cancer at 52; underwent total hysterectomy with poor prognosis.
Lawyer-estimated tier: Tier 3 ($600K–$1.5M+, estimate only). Top-tier MDL cases anchor settlement ranges; actual amounts depend on bellwether jury verdicts.
Profile 4 — Wrongful Death (Surviving Family Member)
Mother used relaxers for 30+ years, died of uterine cancer at 58. Adult daughter inquires whether the estate has a claim.
Yes — wrongful-death pathway may apply, filed by estate / next of kin depending on state law. Lawyer-estimated case values for documented wrongful-death claims often anchor at the top of the Tier 3 range. Consult an MDL-experienced attorney.
Profile 5 — Limited Use, No Documented Diagnosis
Used a chemical relaxer twice in college; no cancer or fibroid diagnosis.
Not eligible. Class requires a documented qualifying diagnosis (uterine, endometrial, or ovarian cancer, or uterine fibroids) with meaningful relaxer-exposure history.
Current MDL Status (May 2026)
Where the case actually stands. <strong>No settlement, no payouts, no claim form.</strong> What plaintiffs can do right now is preserve their right to file before statute of limitations runs out and assemble medical/product-use documentation.
Sources: MDL 3060 docket (N.D. Ill., Judge Rowland), public statements from MDL plaintiffs’ steering committee, defendant public filings.
Who May Be Eligible to Join the MDL
Plaintiffs’ firms generally evaluate prospective cases on these criteria. This is not legal advice — only a licensed plaintiffs’ attorney can confirm whether your situation qualifies.
- You used chemical hair relaxers (e.g., Dark & Lovely, Just for Me, Optimum Care, Motions, ORS Olive Oil, African Pride, Soft & Beautiful) over a meaningful period of time — typically multiple years of regular use
- You were diagnosed with one of the linked conditions: uterine cancer, endometrial cancer, ovarian cancer, or uterine fibroids
- The diagnosis was made after a period of significant relaxer exposure
- You can provide medical records documenting the diagnosis
- You can describe your relaxer-product history (brand, frequency, years of use) — even approximate
Statute of limitations varies by state and by the discovery rule, but is generally 2 to 6 years from diagnosis or from when you knew (or should have known) the link. The MDL’s short-form complaint bellwether eligibility deadline was February 1, 2024 — but new cases can still be filed into the MDL subject to state SOL.
Hair Relaxer MDL vs Other Active Cosmetic / Pharma MDLs
How Hair Relaxer compares to other active mass-tort litigations the public often confuses it with.
| Hair Relaxer MDL | Other Active MDLs | |
|---|---|---|
| Who qualifies | Users of chemical hair relaxers with diagnosed uterine, endometrial, ovarian cancer or fibroids | Defined per each MDL’s class (e.g., Talcum Powder ovarian/mesothelioma; Tepezza hearing loss) |
| Fund / settlement status | No global fund — settlement-stage not reached | Varies: Talcum has billion-dollar verdicts; Tepezza pre-settlement; others mid-stream |
| Distribution timing | No payouts yet; bellwether trials TBD | Varies — some MDLs paying out, others still in trial phase |
| Defendants | L’Oréal, SoftSheen-Carson, Strength of Nature, others | Single or multiple defendants depending on MDL |
| Filing deadline | State SOL (2–6 years typical, discovery rule may apply) | Each MDL has its own filing deadlines and SOL rules |
| Court / docket | MDL 3060, U.S. District Court, N.D. Illinois (Judge Rowland) | Each MDL is docketed before a different federal district court |
Reported Case-Value Ranges (Lawyer Estimates Only)
Plaintiffs’ firms publish estimated per-person case-value ranges, often cited at $100,000 to $1,500,000. These are lawyer projections drawn from comparable mass-tort outcomes, NOT a Hair Relaxer settlement amount and NOT a court verdict. The actual range will only be known after bellwether trials and any settlement framework.
- Lower tier: uterine fibroids with limited documentation of relaxer use.
- Middle tier: endometrial / ovarian cancer with documented multi-year relaxer use.
- Top tier: uterine cancer with strong documentation, severe outcomes (hysterectomy, infertility, death of a loved one).
| Tier | Source | Estimated Range |
|---|---|---|
| Tier 1 — Uterine fibroids only | Lawyer-estimated range | ~$75,000–$200,000 (estimate, not a verdict) |
| Tier 2 — Endometrial or ovarian cancer | Lawyer-estimated range | ~$200,000–$600,000 (estimate, not a verdict) |
| Tier 3 — Uterine cancer, severe outcomes | Lawyer-estimated range (top-tier MDL cases) | $600,000–$1,500,000+ (estimate; depends on bellwether outcomes) |
Hair Relaxer Litigation Timeline
- 1
October 2022: NIH Sister Study Published
An NIH-funded prospective cohort study (the Sister Study, Wise et al.) reports an association between frequent chemical hair-relaxer use and uterine cancer incidence. This study becomes the scientific anchor for subsequent litigation.
- 2
Late 2022 – 2023: Initial Filings Surge
Plaintiffs’ firms begin accepting cases nationwide. Hundreds of complaints filed in state and federal courts against L’Oréal, SoftSheen-Carson, Strength of Nature, and other manufacturers.
- 3
February 2023: MDL Consolidation in N.D. Illinois
The Judicial Panel on Multidistrict Litigation consolidates federal Hair Relaxer cases into MDL 3060 before Judge Mary M. Rowland in the U.S. District Court for the Northern District of Illinois.
- 4
February 1, 2024: Bellwether Short-Form Complaint Deadline
Court-set deadline for plaintiffs to file a short-form complaint to be considered in the bellwether-selection pool. Cases filed later remain in the MDL but are typically not eligible for the initial bellwether group.
- 5
2024–2026: Discovery, Bellwether Selection, Pretrial
MDL case inventory grows to ~9,800+ by 2025. Court oversees corporate-document discovery, expert reports, and selection of bellwether (test) cases. No global settlement framework has been announced. Bellwether trial dates have not been firmly scheduled as of May 2026 — check the MDL docket for the current status.
Why This Case Matters
Hair Relaxer is one of the largest and most racially significant pharmaceutical / consumer-product MDLs of the decade — the vast majority of regular relaxer users are Black women, and the underlying Sister Study specifically examined that population. Outcomes will affect (a) FDA and FTC labeling requirements for cosmetics with endocrine-disrupting ingredients, (b) the playbook for future cosmetic mass torts, and (c) compensation for affected plaintiffs. Related active MDLs in adjacent zones: Talcum Powder, Tepezza Hearing Loss, Tylenol Autism.
Hair Relaxer Lawsuit Scams — Don’t Get Tricked
Pre-settlement mass torts attract scammers because eligible patients are hopeful and motivated. These are the most common Hair Relaxer-specific scam patterns to recognize.
⚠️ “Guaranteed Hair Relaxer payout” promises
There is no settlement and no payout schedule. Anyone — ad, call, social-media post — promising a specific guaranteed dollar amount is misleading you. Legitimate plaintiffs’ attorneys discuss estimated ranges and clearly disclose uncertainty.
⚠️ Fee demands before retainer signed
Real MDL plaintiffs’ attorneys work on contingency — paid only if you recover. No legitimate firm requires up-front fees, claim-processing fees, or “evaluation deposits.”
⚠️ Calls asking for SSN, bank, or Medicare/Medicaid numbers before retainer signed
An attorney needs basic medical-records authorization and contact info to evaluate. Detailed financial / SSN / Medicare data should not be collected by cold-callers ahead of a signed engagement.
⚠️ Settlement “check release” advance fees
Because no settlement exists, anyone claiming to need a small fee to “release your Hair Relaxer settlement check” is running an advance-fee fraud. Hang up.
⚠️ Lead-gen sites that don’t disclose they’re middlemen
Many “Hair Relaxer settlement” websites are pure lead-gen and sell your info to multiple firms. Look for clear attorney disclosures and a named law firm; if it’s anonymous and ad-driven, treat it skeptically.
Hair Relaxer Lawsuit FAQs
Has the Hair Relaxer lawsuit been settled?
No. As of May 2026, no global Hair Relaxer settlement has been announced. The MDL is in active discovery and bellwether-selection phase before Judge Rowland in the Northern District of Illinois. Any source promising a settlement amount is wrong.
How much will I get from a Hair Relaxer lawsuit?
Nobody knows yet, because no settlement has been agreed and no jury has decided a Hair Relaxer MDL case. Plaintiffs’ lawyers publish estimated ranges (often quoted as $100K–$1.5M depending on diagnosis severity), but these are projections from comparable mass torts, not verdicts.
Which hair relaxer brands are named in the lawsuits?
Common brands referenced in MDL complaints include Dark & Lovely, Just for Me, Optimum Care, Motions, ORS Olive Oil, African Pride, Soft & Beautiful, Mizani, Affirm, Designer Touch, and others. Manufacturers named include L’Oréal USA, SoftSheen-Carson, Strength of Nature, and additional companies.
Is it too late to file?
Maybe — it depends on your state and when you were diagnosed. Statute of limitations clocks run 2 to 6 years (typical), often from diagnosis or from when you knew/should have known of the link. The MDL bellwether short-form complaint deadline was February 1, 2024, but new cases continue to be filed into the MDL subject to state SOL. Don’t wait — missing the deadline permanently bars the claim.
Do I need to pay an attorney up front?
No. MDL plaintiffs’ firms work on contingency — they’re paid a percentage of any recovery (commonly around 33–40%). If there’s no recovery, you owe no fee. Up-front fees are a red flag.
Can I join the lawsuit if my mother/sister/daughter died of uterine cancer?
Yes — a wrongful-death pathway may apply, filed by the estate or surviving family members depending on state law. Documented multi-year relaxer use plus uterine/endometrial/ovarian cancer cause of death typically anchors a strong claim. Consult an MDL-experienced attorney about timing and standing.
Is the lawsuit a class action, or do I file individually?
It’s an MDL (multidistrict litigation), not a single class action. Each plaintiff files an individual case consolidated for pretrial purposes. Cases are evaluated and (potentially) resolved individually, not as a single class with one recovery split among all members.
Will my Hair Relaxer recovery (if any) be taxable?
Compensation for personal physical injury or sickness is generally not taxable under IRC Section 104(a)(2). Punitive-damages portions and interest are usually taxable. This is not tax advice — consult a tax professional if you receive a recovery.
What’s Still Uncertain
Every dollar figure on this page is a lawyer estimate. No global Hair Relaxer settlement has been announced. Bellwether trials have not yet produced verdicts. Causation evidence continues to develop. Numbers will only firm up after (a) bellwether jury outcomes and (b) any settlement framework — neither has happened as of May 2026. We update this page when material developments occur.